PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15177893-4	2004	In this study, induction of LMP1 increased the EGFR in both protein and promoter levels in a dose dependent manner using tetracycline-regulated LMP1 expression in nasopharyngeal carcinoma (NPC) cell line.	Tetracycline	121-133	PDZ and LIM domain 7	Homo sapiens	28-32	
15177893-4	2004	In this study, induction of LMP1 increased the EGFR in both protein and promoter levels in a dose dependent manner using tetracycline-regulated LMP1 expression in nasopharyngeal carcinoma (NPC) cell line.	Tetracycline	121-133	PDZ and LIM domain 7	Homo sapiens	144-148	
15115657-4	2004	In this study, induction of LMP1 increased the EGFR in both protein and promoter levels in a dose-dependent manner using tetracycline-regulated LMP1 expression in nasopharyngeal carcinoma (NPC) cell line.	Tetracycline	121-133	PDZ and LIM domain 7	Homo sapiens	28-32	
15115657-4	2004	In this study, induction of LMP1 increased the EGFR in both protein and promoter levels in a dose-dependent manner using tetracycline-regulated LMP1 expression in nasopharyngeal carcinoma (NPC) cell line.	Tetracycline	121-133	PDZ and LIM domain 7	Homo sapiens	144-148	
12504573-3	2002	Using the epithelial cell line HeLa in which the expression of LMP1 is inducibly regulated by tetracycline, we demonstrate that apoptosis triggered by ligation of the death receptor, Fas, or by the chemotherapeutic agent, etoposide, is potentiated by LMP1.	Tetracycline	94-106	PDZ and LIM domain 7	Homo sapiens	63-67	
14523478-5	2003	Similarly, induction of LMP1 in the 3A4 cells (exposed to tetracycline) was accompanied by a 13-fold increase in lymphotoxin levels (ELISA) as compared to uninduced (LMP1-negative) cells.	Tetracycline	58-70	PDZ and LIM domain 7	Homo sapiens	24-28	
12549222-5	2001	We further showed that telomerase activation in infected cells was dependent on the protein level of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus using a Tetracycline regulatory cell line expressing LMP1, pTet-on-LMP1-HNE2.	Tetracycline	172-184	PDZ and LIM domain 7	Homo sapiens	128-132	
11780335-2	2001	METHODS: A tetracycline-regulated LMP1-expressing nasopharyngeal carcinoma cell line, Tet-on-LMP1-HNE2, was used as the cell model.	Tetracycline	11-23	PDZ and LIM domain 7	Homo sapiens	34-38	
11780335-2	2001	METHODS: A tetracycline-regulated LMP1-expressing nasopharyngeal carcinoma cell line, Tet-on-LMP1-HNE2, was used as the cell model.	Tetracycline	11-23	PDZ and LIM domain 7	Homo sapiens	93-97	
11783085-2	2001	METHODS: A nasopharyngeal carcinoma cell line, Tet-on-LMP1 HNE2, transfected with LMP1, the expression of which was regulated by tetracycline, was used in this study.	Tetracycline	129-141	PDZ and LIM domain 7	Homo sapiens	82-86	
15995625-4	2005	METHODS: Tet-on LMP1 HNE2, a tetracycline-regulated LMP1-expression nasopharyngeal carcinoma cell line, was used as cell model.	Tetracycline	29-41	PDZ and LIM domain 7	Homo sapiens	52-56	
9351829-8	1997	Using a tetracycline-regulated LMP-1 allele, we demonstrate that JNK is also an effector of non-cytotoxic LMP-1 signaling in B cells, the physiological target cells of EBV.	Tetracycline	8-20	PDZ and LIM domain 7	Homo sapiens	31-36	
9351829-8	1997	Using a tetracycline-regulated LMP-1 allele, we demonstrate that JNK is also an effector of non-cytotoxic LMP-1 signaling in B cells, the physiological target cells of EBV.	Tetracycline	8-20	PDZ and LIM domain 7	Homo sapiens	106-111